BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 9371306)

  • 1. von Willebrand's factor and von Willebrand's disease.
    Matsushita T; Dong Z; Sadler JE
    Curr Opin Hematol; 1994 Sep; 1(5):362-8. PubMed ID: 9371306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment.
    Turitto VT; Weiss HJ; Baumgartner HR
    J Lab Clin Med; 1983 Oct; 102(4):551-64. PubMed ID: 6413629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease.
    Clemetson KJ; Clemetson JM
    Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD
    Ann Clin Lab Sci; 1989; 19(3):184-9. PubMed ID: 2499240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.
    Weiss HJ; Turitto VT; Baumgartner HR
    J Lab Clin Med; 1978 Nov; 92(5):750-64. PubMed ID: 309498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease.
    Facey DA; Favaloro EJ; Koutts J; Berndt MC; Hertzberg MS
    Br J Haematol; 1999 May; 105(2):538-41. PubMed ID: 10233434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR; Zimmerman TS
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Willebrand's disease and multimeric analysis of the Willebrand factor].
    Hauert J; Tran-Thang C; Bachmann F
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1773-5. PubMed ID: 3879003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of von Willebrand's disease.
    Rick ME
    Clin Lab Med; 1994 Dec; 14(4):781-94. PubMed ID: 7874871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood.
    Badimon L; Badimon JJ; Rand J; Turitto VT; Fuster V
    J Lab Clin Med; 1987 Nov; 110(5):634-47. PubMed ID: 3312444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
    Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
    Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intermittent thrombocytopenia as a manifestation of Von Willebrand's disease].
    Gómez García EB; Brouwers GJ; Kappers-Klunne MC; Leebeek FW; van Vliet HH
    Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1192-5. PubMed ID: 12109311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
    Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.